Welcome to LookChem.com Sign In|Join Free

CAS

  • or

503828-19-1

3-(1H-1,2,3,4-Tetrazol-5-yl)-9H-carbazole is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

503828-19-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 503828-19-1 Structure

  • Basic information

    1. Product Name: 3-(1H-1,2,3,4-Tetrazol-5-yl)-9H-carbazole
    2. Synonyms: 3-(1H-1,2,3,4-Tetrazol-5-yl)-9H-carbazole;(2E)-But-2-enedioic acid bis(tert-butyl 4-[(methylamino)methyl]piperidine-1-carboxylate)
    3. CAS NO:503828-19-1
    4. Molecular Formula: C13H9N5
    5. Molecular Weight: 235.24406
    6. EINECS: 800-220-4
    7. Product Categories: N/A
    8. Mol File: 503828-19-1.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 3-(1H-1,2,3,4-Tetrazol-5-yl)-9H-carbazole(CAS DataBase Reference)
    10. NIST Chemistry Reference: 3-(1H-1,2,3,4-Tetrazol-5-yl)-9H-carbazole(503828-19-1)
    11. EPA Substance Registry System: 3-(1H-1,2,3,4-Tetrazol-5-yl)-9H-carbazole(503828-19-1)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 503828-19-1(Hazardous Substances Data)

503828-19-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 503828-19-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,3,8,2 and 8 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 503828-19:
(8*5)+(7*0)+(6*3)+(5*8)+(4*2)+(3*8)+(2*1)+(1*9)=141
141 % 10 = 1
So 503828-19-1 is a valid CAS Registry Number.

503828-19-1Relevant articles and documents

PHARMACEUTICAL PREPARATIONS COMPRISING INSULIN, ZINC IONS AND A ZINC-BINDING LIGAND

-

Page/Page column 268, (2008/06/13)

Novel preparations comprising branched ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer. The preparations have a prolonged action designed for flexible injection regimes.

PHAMACEUTICAL PREPARATIONS COMPRISING INSULIN

-

Page/Page column 263, (2010/02/15)

Novel preparations comprising ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer wherein the ligand is extended by protamine that are capable of prolonging the ac-tion of insulin preparations.

Stabilised insulin compositions

-

Page/Page column 143, (2008/06/13)

The present invention provides pharmaceutical compositions comprising insulin and novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer. The resulting preparations have improved physical and chemical stability.

PHARMACEUTICAL PREPARATIONS COMPRISING ACID-STABILISED INSULIN

-

Page/Page column 264-265, (2010/02/08)

Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer that are capable of prolonging the action of insulin preparations are disclosed.

Novel ligands for the hisb10 zn2+ sites of the r-state insulin hexamer

-

Page 94, (2010/11/30)

Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer that are capable of prolonging the action of insulin preparations are disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 503828-19-1